Ubs Group Ag Eton Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 135,352 shares of ETON stock, worth $1.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

135,352

Previous 19,017 611.74%

Holding current value

$1.98 Million

Previous $114,000 1460.53%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$5.9 - $13.15 $686,376 - $1.53 Million	116,335 Added 611.74%	135,352 $1.78 Million
Q3 2024 Nov 14, 2024	BUY	$3.28 - $6.0 $26,236 - $47,994	7,999 Added 72.6%	19,017 $114,000
Q2 2024 Aug 13, 2024	BUY	$3.06 - $3.75 $27,717 - $33,967	9,058 Added 462.14%	11,018 $36,000
Q1 2024 May 13, 2024	SELL	$3.48 - $5.03 $6,236 - $9,013	-1,792 Reduced 47.76%	1,960 $7,000
Q4 2023 Feb 09, 2024	BUY	$3.45 - $4.66 $9,763 - $13,187	2,830 Added 306.94%	3,752 $16,000
Q3 2023 Nov 09, 2023	BUY	$2.55 - $5.63 $2,351 - $5,190	922 New	922 $3,000
Q1 2023 May 12, 2023	BUY	$2.89 - $4.1 $4,184 - $5,936	1,448 Added 36.76%	5,387 $20,000
Q4 2022 Feb 08, 2023	SELL	$2.02 - $3.25 $5,037 - $8,105	-2,494 Reduced 38.77%	3,939 $11,000
Q3 2022 Nov 10, 2022	BUY	$2.04 - $3.03 $5,436 - $8,074	2,665 Added 70.73%	6,433 $14,000
Q2 2022 Aug 10, 2022	SELL	$2.55 - $4.38 $2,006 - $3,447	-787 Reduced 17.28%	3,768 $10,000
Q1 2022 May 16, 2022	BUY	$3.43 - $4.69 $1,632 - $2,232	476 Added 11.67%	4,555 $20,000
Q4 2021 Feb 14, 2022	BUY	$3.66 - $6.59 $14,929 - $26,880	4,079 New	4,079 $17,000
Q3 2021 Nov 15, 2021	SELL	$4.2 - $6.26 $22,524 - $33,572	-5,363 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$5.71 - $8.85 $4,973 - $7,708	871 Added 19.39%	5,363 $33,000
Q1 2021 May 12, 2021	SELL	$6.93 - $10.07 $7,297 - $10,603	-1,053 Reduced 18.99%	4,492 $33,000
Q4 2020 Feb 11, 2021	BUY	$6.65 - $8.83 $10,247 - $13,607	1,541 Added 38.49%	5,545 $45,000
Q3 2020 Nov 12, 2020	SELL	$4.96 - $9.06 $3,863 - $7,057	-779 Reduced 16.29%	4,004 $32,000
Q2 2020 Jul 31, 2020	SELL	$3.5 - $6.09 $6,818 - $11,863	-1,948 Reduced 28.94%	4,783 $26,000
Q1 2020 May 01, 2020	BUY	$2.87 - $7.47 $11,999 - $31,232	4,181 Added 163.96%	6,731 $28,000
Q4 2019 Feb 14, 2020	BUY	$5.59 - $7.2 $14,254 - $18,360	2,550 New	2,550 $18,000
Q3 2019 Nov 14, 2019	SELL	$5.19 - $8.72 $6,170 - $10,368	-1,189 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$7.1 - $8.39 $52,206 - $61,691	-7,353 Reduced 86.08%	1,189 $9,000
Q1 2019 May 14, 2019	BUY	$5.72 - $8.0 $48,860 - $68,336	8,542 New	8,542 $68,000

Others Institutions Holding ETON

# of Institutions

Shares Held

13.1M

Call Options Held

284K

Put Options Held

4.2K

View Full List

About Eton Pharmaceuticals, Inc.

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $370M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

More about ETON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account